| Home | Login or Become a Member | Sitemap |
About Diabetes

Type 1 diabetes
Type 2 diabetes
Gestational diabetes
Pre diabetes
Diabetes dictionary
Targets for prevention
Your kidneys & diabetes
Kids
Teens
Parents & carers
Meet Barnaby Bee
Kids & Teens membership
What is diabetes?
You are at risk
Physical activity
Food for thought
10 Ways to manage diabetes
Gestational diabetes
Alcohol
Smoking
HypoglycaemiaLiving Well with Diabetes


How to eat well
For older people
Managing your weight
Eating out
Reading food labels
Glycemic Index
Healthy shopping tours
Recipe of the week
Dessert of the month
Smoking
Driving
Travelling
Alcohol
How to drink safely
Dental health
Sexual health
Mental health
Patient empowerment
Influenza awarenessDiabetes Prevention

Diabetes facts
Check your risk
Managing weight & lifestyle
Lifestyle changes
What your number means
Norm's story
Weight management
Diagnostic Guidelines
Glycemic index
Prevent or delay Type 2
Case detection & diagnosis
Lifestyle: the evidence
Patients with pre-diabetes
Diabetes services guide
About Us

How we are Governed
Business Overview
The Board
Executive Leadership Team
Patrons, President and Executive
Benefits & deals
Fees & categories
Membership and NDSS
Safeguard life insurance
Online services for members
Being Heard campaign
Branches & Support Groups
Workplace discrimination
The diabetes team
Support Network Stories
Event & campaign sponsors
Suppliers
Trusts & foundations
Sponsorship opportunities
Celebrity Supporters
Events











Research

Health Professionals

Type 1 diabetes
Type 2 diabetes
Pre-diabetes
Gestational diabetes
Physical activity
Healthy eating
Polycystic Ovarian Syndrome
Coeliac disease & diabetes
Audio Information Sheets
About diabetes CD-ROM
Diabetes Faxback program
For non-English speakers
Renal Complications
Diabetes & kidney disease
Check your kidneys too
Healthy eating for the elderly
Diabetes care for the elderly
Obesity management
Diabetic foot
Media & Publications

| 04 March 2010 |
| A message from the CEO of Diabetes Australia-NSW on Australian Government Health Reforms |
| The Australian Government yesterday announced major reforms to Australia’s health and hospital system. |
| 26 February 2010 |
| Diabetes increases dementia risk in older people |
| British researchers have found that older people with mild cognitive impairment are three times more likely to develop dementia if they have diabetes. |
| 09 March 2010 |
| Combined diet and exercise the key to improving insulin resistance |
| Combining diet and exercise rather than diet and exercise alone leads to significantly greater improvements in body fat distribution and insulin resistance, according to the findings of a new study. |
| 04 March 2010 |
| Salt intake linked with stroke, heart disease risk |
| A new Italian study suggests that by lowering our salt intake we could substantially reduce the amount of deaths from heart disease and stroke worldwide. |
| Home > Media & Publications > Research... |
20 February 2008
For over 80 years, injections have been the only way of delivering insulin to people with diabetes, but new studies have brought oral insulin a step closer.
A major problem for oral insulin is that acids in the stomach destroy insulin before it can have a suitable effect on blood glucose.
The first study, by Syracuse University in New York and published in the December issue of journal ChemMedChem, tried to solve this problem by binding insulin to vitamin B-12. The vitamin B-12 carries and protects the insulin in the stomach, allowing the insulin to be absorbed into the blood through the small intestine.
While the results were promising, the researchers discovered that vitamin B-12 only had a limited capacity to be absorbed, meaning not enough insulin was being taken in to have sufficient effect.
The second and third studies, carried out by Indian researchers, took this idea further but rather than binding one insulin molecule to one vitamin B-12 molecule, they coated a nanoparticle with multiple B-12 molecules. This increased the ability of vitamin B-12 absorption in the intestine, therefore increasing the amount of insulin being absorbed into the blood.
Their findings, published in the Journal of Controlled Release, were that using this method, up to 36,000 insulin molecules can be taken up for every one vitamin B-12 molecule absorbed into the blood, resulting in blood glucose levels being lowered to the normal range.
So far, this method of oral insulin has only been tested in animals, with the researchers now preparing to move into human trials.
Other new forms of insulin delivery are also being researched, such as inhaled insulin, but so far results have been mixed.
Sources:
- Petrus, Vortherms, Fairchild, Doyle. Vitamin B12 as a Carrier for the Oral Delivery of Insulin. ChemMedChem, Volume 2 Issue 12;1661-1838; 10 December, 2007
- Kishore et al. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. Journal of Controlled Release, Volume 122, Issue 2;141-150;26 September 2007
|
|
|
|
|
|

